RSS Feeds
Misdiagnosis of HIV Infection by HIV-1 Plasma Viral Load Testing: A Case Series
- Josiah D. Rich, MD, MPH;
- Nathan A. Merriman, ScB;
- Eleftherios Mylonakis, MD;
- Thomas C. Greenough, MD;
- Timothy P. Flanigan, MD;
- Brian J. Mady, MD; and
- Charles C.J. Carpenter, MD
- From Brown University School of Medicine, Providence, Rhode Island; and the University of Massachusetts School of Medicine, Worcester, Massachusetts.
Abstract
Background: The availability of sensitive assays for plasma HIV viral load and the trend toward earlier and more aggressive treatment of HIV infection has led to the inappropriate use of these assays as primary tools for the diagnosis of acute HIV infection.
Objective: To describe limitations in the use of plasma viral load testing for the diagnosis of HIV infection.
Design: Case series.
Setting: Academic medical centers in Providence, Rhode Island, and Worcester, Massachusetts.
Patients: Three persons in whom HIV infection was falsely diagnosed by plasma viral load testing.
Measurements: Laboratory measures and clinical outcomes.
Results: Two cases of false-positive results obtained by using branched-chain DNA plasma viral load assays and one case of a false-positive result obtained by using reverse transcriptase-polymerase chain reaction plasma viral load assay are reported. All three plasma viral load tests yielded positive results with low values (1254 copies/mL, 1574 copies/mL, and 1300 copies/mL). Infection with HIV was initially diagnosed in all three patients, but each patient subsequently tested negative by HIV-1 enzyme-linked immunosorbent assay and repeated plasma viral load testing.
Conclusion: Physicians should exercise caution when using plasma viral load assays to detect primary HIV infection, particularly when the pretest probability of infection is low.
- Human immunodeficiency virus infections
- False positive reactions
- Viral load
- Anti-HIV agents
- Human immunodeficiency virus-1
Article and Author Information
-
Requests for Reprints: Josiah D. Rich, MD, MPH, Department of Medicine, Miriam Hospital/Brown University School of Medicine, 164 Summit Avenue, Providence, RI 02906; e-mail, josiah_rich@Brown.edu.
-
Current Author Addresses: Drs. Rich, Mylonakis, Carpenter, and Flanigan: Department of Medicine, Miriam Hospital/Brown University School of Medicine, 164 Summit Avenue, Providence, RI 02906.
-
Mr. Merriman: University of North Carolina, Chapel Hill, Chapel Hill, NC 27514.
-
Drs. Greenough and Mady: University of Massachusetts Medical Center, 373 Plantation Street, Suite 318, Worcester, MA 01605.
-
Acknowledgments: The authors thank Gloria Magnano for her tireless and enthusiastic secretarial support.
-
Grant Support: Dr. Rich is supported by grant K20 DA00268 from the National Institute on Drug Abuse.
- Copyright ©2004 by the American College of Physicians
